• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Triathlon Medical Venture Partners

edit

Whether you’re an entrepreneur or a venture capitalist, you’ll find a warm welcome at Triathlon Medical Ventures. Prior to opening our doors in 2004, Triathlon’s team has been investing in life science business opportunities for more than fifteen years. And we are also industry veterans, experienced at growing medical device and biotechnology companies from the inside out - as owners, directors and operational managers.

Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. We provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs.

Milestones

edit

• 
  Triathlon Medical Venture Partners invested in Mitralign. (5/16/12)
  Posted 5/16/12 at 5:54pm via finsmes.com
• 
  Triathlon Medical Venture Partners invested in Akebia Therapeutics. (1/9/12)
  Posted 1/9/12 at 7:18pm via finsmes.com
• 
  Triathlon Medical Venture Partners invested in CoLucid Pharmaceuticals. (8/30/11)
  Posted 8/30/11 at 7:57pm via prnewswire.com
• 
  Triathlon Medical Venture Partners invested in Akebia Therapeutics. (4/26/11)
  Posted 4/26/11 at 5:12pm via akebia.com
• 
  Triathlon Medical Venture Partners invested in Endocyte. (1/19/10)
  Posted 1/20/10 at 9:32pm via onbiovc.com
• 
  Triathlon Medical Venture Partners invested in CS-Keys. (1/25/08)
  Posted 12/18/09 at 3:41am via ceresventurefund.com
• 
  Triathlon Medical Venture Partners invested in Akebia Therapeutics. (9/15/09)
  Posted 9/18/09 at 5:15am via onbiovc.com
• 
  Triathlon Medical Venture Partners invested in Tolera Therapeutics. (6/16/08)
  Posted 5/27/09 at 1:54am
• 
  Triathlon Medical Venture Partners invested in BioVex. (3/30/09)
  Posted 3/30/09 at 2:17pm via fiercebiotech.com

Investments

Videos

Sources

1. Mitralign Closes $35M in Series D Financing (finsmes.com) [edit]
2. Akebia Therapeutics Raises $4.1M in Series B Financing (finsmes.com) [edit]
3. CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million (prnewswire.com) [edit]
4. AKEBIA COMPLETES $22M SERIES B FINANCING (akebia.com) [edit]
5. Endocyte, Inc.: Series C $26M (onbiovc.com) [edit]
6. Akebia Therapeutics, Inc.: Series A $16M (onbiovc.com) [edit]
7. BioVex Raises $40 Million (fiercebiotech.com) [edit]
8. Capital Funding Report [edit]
9. Ceres Venture Fund Invests in $6.25 Million Series A Round for Cancer-Specific Biomarker Company CS-Keys, Inc. (ceresventurefund.com) [edit]